FORWARD FEATURES CALENDAR

Deals

Andera Partners supports TargED Biopharmaceuticals in EUR39m Series A financing

TargED Biopharmaceuticals (TargED), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has raised Series A financing of EUR39 million to accelerate development of its lead compound, Microlyse. The financing was led by an international syndicate with equal contributions from Andera Partners, Fund+, Hadean Ventures, Inkef Capital

Hambro Perks invests in Altum Technologies

Hambro Perks has completed an investment in Finnish industrial technology business Altum Technologies. Headquartered in Helsinki and founded in 2016, Altum has developed market-leading power ultrasound technology to clean fouling from industrial equipment without stopping production. Altum’s patented ZPD technology also minimises maintenance time, energy consumption and use of hazardous

Beaufort Capital and Pollen Street Capital launch strategic JV

Beaufort Capital and Pollen Street Capital have formed a strategic joint venture to improve access to finance for high quality real estate developers nationwide. The new lending partnership is expected to fund senior and stretched senior loans to support the development of much needed homes across the UK, as well

Planet Smart City launches EUR60m capital raise

Planet Smart City, a London headquartered specialist in smart affordable housing, has launched a EUR60 million capital raise to accelerate the Group’s ambitious business plans. Since its establishment in 2015, Planet Smart City, which specialises in large-scale projects that create smart neighbourhoods and affordable homes – has raised more than

Semarion raises GBP2.14 million in seed funding round led by Parkwalk Advisors

Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, has closed a GBP2.14 million seed funding round led by Parkwalk Advisors. University of Cambridge Seed Funds, Martlet Capital, and angel investors also contributed to the

Jeito Capital co-leads USD65 million Series A financing in EyeBio

Jeito Capital (Jeito), an independent private equity firm dedicated to biotech and biopharma, has co-led a USD65 million Series A financing round in EyeBiotech Limited (EyeBio), a privately held ophthalmology biotechnology company working to deliver a new generation of therapies for eye diseases.

Beyond Identity raises USD100m in Series C round led by Evolution Equity Partners

Multi-factor authentication (MFA) provider Beyond Identity has closed a USD100 million Series C funding round led by Evolution Equity Partners. Existing investors New Enterprise Associates (NEA) and Jim Clark also participated in the round, which brings the company’s total funding to date to USD205 million and propels its valuation to

Events

12 November, 2026 – 5:00 pm

Directory Listings